Compositions for modulating C9ORF72 expression
US10815483B2 · kind B2 · utility
2Cited by
5References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 17, 2018 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Oct 17, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for reducing expression of C9ORF72 mRNA and protein in an animal. Such methods are useful to treat, prevent, ameliorate, or slow progression of neurodegenerative diseases in an individual in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.